ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 132 filers reported holding ENDOLOGIX INC in Q1 2017. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $330,000 | -27.3% | 67,825 | +8.2% | 0.00% | -25.0% |
Q1 2017 | $454,000 | +8.1% | 62,685 | -14.6% | 0.00% | 0.0% |
Q4 2016 | $420,000 | -58.0% | 73,390 | -6.0% | 0.00% | -55.6% |
Q3 2016 | $999,000 | +3.7% | 78,080 | +1.1% | 0.01% | 0.0% |
Q2 2016 | $963,000 | +45.5% | 77,265 | -2.4% | 0.01% | +50.0% |
Q1 2016 | $662,000 | – | 79,185 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 1,165,428 | $35,549,000 | 17.87% |
Iguana Healthcare Management, LLC | 160,000 | $2,790,000 | 1.59% |
Elk Creek Partners, LLC | 112,839 | $1,968,000 | 1.42% |
Tygh Capital Management, Inc. | 338,424 | $5,902,000 | 1.24% |
NEXT CENTURY GROWTH INVESTORS LLC | 2,471,336 | $43,100,000 | 1.19% |
First Light Asset Management, LLC | 75,738 | $1,321,000 | 1.12% |
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 273,954 | $4,778,000 | 1.07% |
WASHINGTON CAPITAL MANAGEMENT, INC | 195,316 | $3,406,000 | 0.82% |
PALISADE CAPITAL MANAGEMENT, LP | 1,605,163 | $27,994,000 | 0.73% |
ArrowMark Colorado Holdings LLC | 1,286,044 | $22,429,000 | 0.70% |